Are We Getting High Cause the Thrill is Gone?

Journal of addiction psychiatry Pub Date : 2023-01-01 Epub Date: 2023-12-08
Kenneth Blum, Thomas Mclaughlin, Mark S Gold, Marjorie C Gondre-Lewis, Panayotis K Thanos, Igor Elman, David Baron, Abdalla Bowirrat, Debamyla Barh, Jag Khalsa, Colin Hanna, Nicole Jafari, Foojan Zeine, Eric R Braverman, Catherine Dennen, Milan T Makale, Miles Makale, Keerthy Sunder, Kevin T Murphy, Rajendra D Badgaiyan
{"title":"Are We Getting High Cause the Thrill is Gone?","authors":"Kenneth Blum, Thomas Mclaughlin, Mark S Gold, Marjorie C Gondre-Lewis, Panayotis K Thanos, Igor Elman, David Baron, Abdalla Bowirrat, Debamyla Barh, Jag Khalsa, Colin Hanna, Nicole Jafari, Foojan Zeine, Eric R Braverman, Catherine Dennen, Milan T Makale, Miles Makale, Keerthy Sunder, Kevin T Murphy, Rajendra D Badgaiyan","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>In the USA alone, opioid use disorder (OUD) affects approximately 27 million people. While the number of prescriptions may be declining due to increased CDC guidance and prescriber education, fatalities due to fentanyl-laced street heroin are still rising. Our laboratory has extended the overall concept of both substance and non-substance addictive behaviors, calling it \"Reward Deficiency Syndrome (RDS).\" Who are its victims, and how do we get this unwanted disorder? Is RDS caused by genes (Nature), environment (Neuro-epigenetics, Nurture), or both? Recent research identifies resting-state functional connectivity in the brain reward circuitry as a crucial factor. Analogously, it is of importance to acknowledge that the cumulative discharge of dopamine, governed by the nucleus accumbens (NAc) and modulated by an array of additional neurotransmitters, constitutes a cornerstone of an individual's overall well-being. Neuroimaging reveals that high-risk individuals exhibit a blunted response to stimuli, potentially due to DNA polymorphisms or epigenetic alterations. This discovery has given rise to the idea of a diminished 'thrill,' though we must consider whether this 'thrill' may have been absent from birth due to high-risk genetic predispositions for addiction. This article reviews this issue and suggests the general concept of the importance of \"induction of dopamine homeostasis.\" We suggest coupling a validated genetic assessment (e.g., GARS) with pro-dopamine regulation (KB220) as one possible frontline modality in place of prescribing potent addictive opioids for OUD except for short time harm reduction. Could gene editing offer a 'cure' for this undesirable genetic modification at birth, influenced by the environment and carried over generations, leading to impaired dopamine and other neurotransmitter imbalances, as seen in RDS? Through dedicated global scientific exploration, we hope for a future where individuals are liberated from pain and disease, achieving an optimal state of well-being akin to the proverbial 'Garden of Eden'.</p>","PeriodicalId":73582,"journal":{"name":"Journal of addiction psychiatry","volume":"7 1","pages":"5-516"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10758019/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of addiction psychiatry","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/12/8 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

In the USA alone, opioid use disorder (OUD) affects approximately 27 million people. While the number of prescriptions may be declining due to increased CDC guidance and prescriber education, fatalities due to fentanyl-laced street heroin are still rising. Our laboratory has extended the overall concept of both substance and non-substance addictive behaviors, calling it "Reward Deficiency Syndrome (RDS)." Who are its victims, and how do we get this unwanted disorder? Is RDS caused by genes (Nature), environment (Neuro-epigenetics, Nurture), or both? Recent research identifies resting-state functional connectivity in the brain reward circuitry as a crucial factor. Analogously, it is of importance to acknowledge that the cumulative discharge of dopamine, governed by the nucleus accumbens (NAc) and modulated by an array of additional neurotransmitters, constitutes a cornerstone of an individual's overall well-being. Neuroimaging reveals that high-risk individuals exhibit a blunted response to stimuli, potentially due to DNA polymorphisms or epigenetic alterations. This discovery has given rise to the idea of a diminished 'thrill,' though we must consider whether this 'thrill' may have been absent from birth due to high-risk genetic predispositions for addiction. This article reviews this issue and suggests the general concept of the importance of "induction of dopamine homeostasis." We suggest coupling a validated genetic assessment (e.g., GARS) with pro-dopamine regulation (KB220) as one possible frontline modality in place of prescribing potent addictive opioids for OUD except for short time harm reduction. Could gene editing offer a 'cure' for this undesirable genetic modification at birth, influenced by the environment and carried over generations, leading to impaired dopamine and other neurotransmitter imbalances, as seen in RDS? Through dedicated global scientific exploration, we hope for a future where individuals are liberated from pain and disease, achieving an optimal state of well-being akin to the proverbial 'Garden of Eden'.

快感消失了,我们就能嗨起来吗?
仅在美国,阿片类药物使用障碍(OUD)就影响着大约 2700 万人。虽然由于疾病预防控制中心(CDC)加强了指导和对处方医生的教育,处方数量可能会有所下降,但由于掺有芬太尼的街头海洛因造成的死亡人数仍在上升。我们的实验室扩展了药物成瘾和非药物成瘾行为的整体概念,称之为 "奖赏缺失综合征(RDS)"。谁是它的受害者,我们又是如何患上这种令人讨厌的疾病的?RDS 是由基因(自然)、环境(神经表观遗传学、养育)还是两者共同造成的?最新研究发现,大脑奖赏回路的静息态功能连接是一个关键因素。与此类似,我们必须承认,多巴胺的累积排出量是个人整体健康的基石,它由脑内核(NAc)支配,并受一系列其他神经递质的调节。神经影像学发现,高危人群对刺激的反应迟钝,这可能是 DNA 多态性或表观遗传学改变所致。这一发现催生了 "快感 "减弱的观点,但我们必须考虑,这种 "快感 "是否可能由于高风险的成瘾遗传倾向而从一出生就不存在。本文回顾了这一问题,并提出了 "诱导多巴胺稳态 "这一重要概念。我们建议将经过验证的基因评估(如 GARS)与促多巴胺调节(KB220)结合起来,作为一种可能的一线治疗方式,以取代开具强效成瘾性阿片类药物来治疗 OUD(短时间减少伤害除外)。基因编辑能否 "治愈 "出生时受环境影响并世代相传的不良基因修饰,从而导致多巴胺和其他神经递质失衡,如 RDS 所见?通过全球范围内的科学探索,我们希望在未来,人们能够从痛苦和疾病中解脱出来,达到一种类似于谚语中 "伊甸园 "的最佳幸福状态。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信